Updated Jul 16, 2026
Simon Amy has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $202K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | BEAM | Beam Therapeutics Inc. | S — Open-market sale | 373 | $34.73 | $13K |
| 2026-04-06 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 6.7K | $24.58 | $165K |
| 2026-04-02 | BEAM | Beam Therapeutics Inc. | A — Grant or award | 31.8K | $0.00 | |
| 2026-01-05 | BEAM | Beam Therapeutics Inc. | A — Grant or award | 12.5K | $0.00 | |
| 2025-07-01 | BEAM | Beam Therapeutics Inc. | S — Open-market sale | 876 | $20.12 | $18K |
| 2025-07-01 | BEAM | Beam Therapeutics Inc. | S — Open-market sale | 374 | $16.94 | $6K |
Simon Amy is a corporate insider — currently tracked as Insider of Beam Therapeutics Inc. (BEAM). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($202K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Simon Amy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.